Tanshinone IIA Reverses EGF- and TGF-β1-mediated Epithelial-mesenchymal Transition in HepG2 Cells Via the PI3K/Akt/ERK Signaling Pathway

Overview

Journal Oncol Lett

Specialty Oncology

Date 2019 Dec 7

PMID 31807174

Citations 12

Authors

Longkai Zhang

Weibin Lin

Xiaodan Chen

Gang Wei

Hailong Zhu

Shangping Xing

Affiliations

Soon will be listed here.

Abstract

Epithelial-to-mesenchymal transition (EMT) is an essential phenotypic conversion involved in cancer progression. Epidermal growth factor (EGF) and transforming growth factor (TGF)-β1 are potent inducers of the EMT. Tanshinone IIA (Tan IIA) is a phenanthrenequinone extracted from the root of Bunge, and its anticancer activity has been demonstrated in numerous studies. However, the mechanisms of action underlying Tan IIA in EGF- and TGF-β1-induced EMT in HepG2 cells remain unknown. Multiple assays were utilized in the present study, including colony formation, wound healing, Transwell invasion, immunofluorescence staining and western blotting, in order to assess the influence of Tan IIA on HepG2 cells induced by 20 ng/ml EGF and 10 ng/ml TGF-β1. The present study reported that Tan IIA treatment decreased EGF- and TGF-β1-enhanced cell colony numbers, migration and invasion, and inhibited EGF- and TGF-β1-induced decreases in the expression levels of E-cadherin, and increases in the expression levels of matrix metalloproteinase-2, N-cadherin, vimentin and Snail. In addition, it was observed that Tan IIA decreased the expression levels of phosphorylated (p)-Akt and p-ERK1/2 induced by EGF and TGF-β1. Furthermore, western blot analysis confirmed that blocking the function of PI3K/Akt and ERK with LY294002 and U0126 resulted in upregulation of E-cadherin expression, and downregulation of vimentin and Snail expression in EGF- and TGF-β1-treated HepG2 cells. In conclusion, to the best of our knowledge, the results of the present study are the first to indicate that Tan IIA may suppress EGF- and TGF-β1-induced EMT in HepG2 cells by deactivating the PI3K/Akt/ERK pathway.

Citing Articles

Signaling pathways behind the biological effects of tanshinone IIA for the prevention of cancer and cardiovascular diseases.

Shahrokhi H, Asili J, Tayarani-Najaran Z, Boozari M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39937254 DOI: 10.1007/s00210-025-03857-x.

The Protective Effects of Curcumin against Renal Toxicity.

Zhai J, Chen Z, Zhu Q, Guo Z, Wang N, Zhang C Curr Med Chem. 2024; 31(35):5661-5669.

PMID: 38549536 DOI: 10.2174/0109298673271161231121061148.

The mechanisms of tanshinone in the treatment of tumors.

Zhang P, Liu W, Wang Y Front Pharmacol. 2023; 14:1282203.

PMID: 37964867 PMC: 10642231. DOI: 10.3389/fphar.2023.1282203.

Polyhydroxylated Fullerene C(OH) Nanofilms Promote the Mesenchymal-Epithelial Transition of Human Liver Cancer Cells via the TGF-β1/Smad Pathway.

Sosnowska M, Kutwin M, Koczon P, Chwalibog A, Sawosz E J Inflamm Res. 2023; 16:3739-3761.

PMID: 37663761 PMC: 10474868. DOI: 10.2147/JIR.S415378.

in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes.

Lu M, Lan X, Wu X, Fang X, Zhang Y, Luo H Front Pharmacol. 2022; 13:1008222.

PMID: 36172186 PMC: 9512245. DOI: 10.3389/fphar.2022.1008222.

References

Liu Z, Kuang W, Zhou Q, Zhang Y . TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway. Int J Mol Med. 2018; 42(6):3395-3403. PMC: 6202079. DOI: 10.3892/ijmm.2018.3923. View

Said N, Williams E . Growth factors in induction of epithelial-mesenchymal transition and metastasis. Cells Tissues Organs. 2010; 193(1-2):85-97. DOI: 10.1159/000320360. View

Pan M, Schinke H, Luxenburger E, Kranz G, Shakhtour J, Libl D . EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers. PLoS Biol. 2018; 16(9):e2006624. PMC: 6177200. DOI: 10.1371/journal.pbio.2006624. View

Lin C, Chang T, Hsieh W, Hung M, Lin I, Lai S . Simultaneous induction of apoptosis and necroptosis by Tanshinone IIA in human hepatocellular carcinoma HepG2 cells. Cell Death Discov. 2016; 2:16065. PMC: 5045965. DOI: 10.1038/cddiscovery.2016.65. View

Zhu Y, Wang B, Wu F, An Y, Zhou X . Influence of Tanshinone IIA on the Apoptosis of Human Esophageal Ec-109 Cells. Nat Prod Commun. 2016; 11(1):17-9. View

Dong W, Zhang Y, Chen X, Jia Y . High-Dose Tanshinone IIA Suppresses Migration and Proliferation While Promoting Apoptosis of Astrocytoma Cells Via Notch-1 Pathway. Neurochem Res. 2018; 43(9):1855-1861. DOI: 10.1007/s11064-018-2601-0. View

Xing S, Yu W, Zhang X, Luo Y, Lei Z, Huang D . Isoviolanthin Extracted from Reverses TGF-β1-Mediated Epithelial⁻Mesenchymal Transition in Hepatocellular Carcinoma Cells via Deactivating the TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways. Int J Mol Sci. 2018; 19(6). PMC: 6032198. DOI: 10.3390/ijms19061556. View

Huang L, Zhu J, Zheng M, Zou R, Zhou Y, Zhu M . Tanshinone IIA protects against subclinical lipopolysaccharide induced cardiac fibrosis in mice through inhibition of NADPH oxidase. Int Immunopharmacol. 2018; 60:59-63. DOI: 10.1016/j.intimp.2018.04.036. View

Miyazono K . Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85(8):314-23. PMC: 3621568. DOI: 10.2183/pjab.85.314. View

10.

Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y . The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma. Sci Rep. 2017; 7:41616. PMC: 5278559. DOI: 10.1038/srep41616. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Pei Z, Fu W, Wang G . A natural product toosendanin inhibits epithelial-mesenchymal transition and tumor growth in pancreatic cancer via deactivating Akt/mTOR signaling. Biochem Biophys Res Commun. 2017; 493(1):455-460. DOI: 10.1016/j.bbrc.2017.08.170. View

13.

Cheng Z, Wei W, Wu Z, Wang J, Ding X, Sheng Y . ARPC2 promotes breast cancer proliferation and metastasis. Oncol Rep. 2019; 41(6):3189-3200. PMC: 6488984. DOI: 10.3892/or.2019.7113. View

14.

Bhat F, Sharmila G, Balakrishnan S, Arunkumar R, Elumalai P, Suganya S . Quercetin reverses EGF-induced epithelial to mesenchymal transition and invasiveness in prostate cancer (PC-3) cell line via EGFR/PI3K/Akt pathway. J Nutr Biochem. 2014; 25(11):1132-1139. DOI: 10.1016/j.jnutbio.2014.06.008. View

15.

Tsai P, Fu Y, Chang L, Lin S . Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells. Toxicon. 2016; 111:108-20. DOI: 10.1016/j.toxicon.2016.01.051. View

16.

Qin J, Shi H, Xu Y, Zhao F, Wang Q . Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity. Biomed Pharmacother. 2018; 105:758-765. DOI: 10.1016/j.biopha.2018.06.028. View

17.

Wendt M, Allington T, Schiemann W . Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol. 2009; 5(8):1145-68. PMC: 2858056. DOI: 10.2217/fon.09.90. View

18.

Sheng W, Chen C, Dong M, Wang G, Zhou J, Song H . Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway. Cell Death Dis. 2017; 8(10):e3147. PMC: 5680916. DOI: 10.1038/cddis.2017.547. View

19.

Ren X, Wang C, Xie B, Hu L, Chai H, Ding L . Tanshinone IIA induced cell death via miR30b-p53-PTPN11/SHP2 signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol. 2016; 796:233-241. DOI: 10.1016/j.ejphar.2016.11.046. View

20.

Mehlen P, Puisieux A . Metastasis: a question of life or death. Nat Rev Cancer. 2006; 6(6):449-58. DOI: 10.1038/nrc1886. View